Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Jazayeri-Tehrani, Seyed Ali, Rezayat, Seyed Mahdi, Mansouri, Siavash, Qorbani, Mostafa, Alavian, Seyed Moayed, Daneshi-Maskooni, Milad, Hosseinzadeh-Attar, Mohammad-JavadVolume:
16
Journal:
Nutrition & Metabolism
DOI:
10.1186/s12986-019-0331-1
Date:
December, 2019
File:
PDF, 899 KB
2019